Gilotrif and Hair disorder - a phase IV clinical study of FDA data

Summary:

Hair disorder is reported as a side effect among people who take Gilotrif (afatinib dimaleate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Multivitamin, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Hair disorder when taking Gilotrif. It is created by eHealthMe based on reports of 6,046 people who have side effects when taking Gilotrif from the FDA, and is updated regularly.

What is Gilotrif?

Gilotrif has active ingredients of afatinib dimaleate. eHealthMe is studying from 6,055 Gilotrif users. Check the latest studies of Gilotrif.

What is Hair disorder?

Hair disorder is found to be associated with 559 drugs and 458 conditions by eHealthMe. Check the latest studies of Hair disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

6,046 people reported to have side effects when taking Gilotrif.
Among them, 19 people (0.31%) have Hair disorder.

Among these 19 people:

How long have people been on Gilotrif when they have Hair disorder? *

What is the gender of people who have Hair disorder when taking Gilotrif? *

female: 89.47 %
male: 10.53 %

What is the age of people who have Hair disorder when taking Gilotrif? *

What are other drugs people take besides Gilotrif? *

What are other side effects people have besides Hair disorder? *

Diarrhea: 17 people, 89.47%
Dry Skin: 12 people, 63.16%
Stomatitis (inflammation of mucous membrane of mouth): 11 people, 57.89%
Fatigue (feeling of tiredness): 10 people, 52.63%
Pain In Extremity: 10 people, 52.63%
Nausea (feeling of having an urge to vomit): 9 people, 47.37%
Onychoclasis (breaking of the nails): 9 people, 47.37%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 42.11%
Rhinorrhea (watery mucus discharge from the nose): 8 people, 42.11%
Weight Decreased: 7 people, 36.84%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 12 people, 63.16%
Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 31.58%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 26.32%
Cough: 5 people, 26.32%
Respiratory Tract Congestion (blockage on respiratory system): 4 people, 21.05%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 10.53%
Type 2 Diabetes: 1 person, 5.26%
Pulmonary Congestion (congestion in the lungs): 1 person, 5.26%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Gilotrif and have Hair disorder?

- Check whether Hair disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gilotrif:

Gilotrif (6,055 reports)

Hair disorder treatments and more:

Hair disorder (13,748 reports)

Browse all side effects of Gilotrif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair disorder:

Hair disorder (559 drugs)

Browse all the conditions that are associated with Hair disorder:

Hair disorder (458 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on afatinib dimaleate (the active ingredients of Gilotrif) and Gilotrif (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.